Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case Series

BACKGROUND: Netherton syndrome (NS) is a rare potential life-threatening disorder that causes severe defects to the skin barrier. No effective treatment options are available for patients with NS and current therapy is mostly supportive. The effects of intravenous immunoglobulins (IVIGs), ixekizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Ragamin, Aviël, Nouwen, Anouk E.M., Dalm, Virgil A.S.H., van Mierlo, Minke M.F., Lincke, Carsten R., Pasmans, Suzanne G.M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909717/
https://www.ncbi.nlm.nih.gov/pubmed/35998563
http://dx.doi.org/10.1159/000525987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909717/
https://www.ncbi.nlm.nih.gov/pubmed/35998563
http://dx.doi.org/10.1159/000525987

Ejemplares similares